2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particles

Journal of Lipid Research

Volumn 51, Issue 6, 2010, Pages 1560-1565

  Blanco, Francisco J ^a,b   Villegas, Sandra ^c   Benítez, Sònia ^d   Bancells, Cristina ^c,d   Diercks, Tammo ^a   Ordóñez Llanos, Jordi ^c,d   Sánchez Quesada, José L ^d  

^a CIC BIOGUNE   (Spain)

^b BASQUE FOUNDATION FOR SCIENCE   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Apolipoprotein B 100; Electronegative low density lipoprotein; Two dimensional nuclear magnetic resonance

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN; LYSINE; PROTEIN P100;

ARTICLE; BINDING AFFINITY; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN; MICROENVIRONMENT; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE; PKA; PRIORITY JOURNAL; PROTEIN CONFORMATION; RECEPTOR AFFINITY; RECEPTOR BINDING; RELIABILITY; SENSITIVITY ANALYSIS;

APOLIPOPROTEIN B-100; ATHEROSCLEROSIS; HUMANS; ISOTOPE LABELING; LIPOPROTEINS, LDL; LYSINE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR;

EID: 77952710230     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.D002642     Document Type: Article

References (26)

1. Tabas, I., K. J. Williams, J. Borén. 2007. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 116: 1832-1844. (Pubitemid 350287108)
2. Segrest, J. P., M. K. Jones, H. De Loof, and N. Dashti. 2001. Structure of apolipoprotein B-100 in low density lipoproteins. J. Lipid Res. 42: 1346-1367. (Pubitemid 34007665)
3. Krauss, R. M. 1995. Dense low density lipoproteins and coronary artery disease. Am. J. Cardiol. 75: 53B-57B.
4. Holvoet, P. 2004. Oxidized LDL and coronary heart disease. Acta Cardiol. 59: 479-484. (Pubitemid 39331216)
5. Sánchez-Quesada, J. L., S. Benítez, and J. Ordóñez-Llanos. 2004. Electronegative low-density lipoprotein. Curr. Opin. Lipidol. 15: 329-335.
6. Benítez, S., V. Villegas, C. Bancells, O. Jorba, F. González-Sastre, J. Ordóñez-Llanos, and J. L. Sánchez-Quesada. 2004. Impaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to nonesterified fatty acids and lysophosphatidylcholine content. Biochemistry. 43: 15863-15872. (Pubitemid 39665085)
7. Bancells, C., S. Benítez, S. Villegas, O. Jorba, J. Ordóñez-Llanos, and J. L. Sánchez-Quesada. 2008. Novel phospholipolytic activities associated with electronegative low-density lipoprotein are involved in increased self-aggregation. Biochemistry. 47: 8186-8194.
8. De Spirito, M., R. Brunelli, G. Mei, F. R. Bertani, G. Ciasca, G. Greco, M. Papi, G. Arcovito, F. Ursini, and T. Parasassi. 2006. Low density lipoprotein aged in plasma forms clusters resembling subendothelial droplets: aggregation via surface sites. Biophys. J. 90: 4239-4247. (Pubitemid 43846138)
9. Parasassi, T., G. Bittolo-Bon, R. Brunelli, G. Cazzolato, E. K. Krasnowska, G. Mei, A. Sevanian, and F. Ursini. 2001. Loss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL(-). Free Radic. Biol. Med. 31: 82-89. (Pubitemid 32568427)
10. Parasassi, T., M. De Spirito, G. Mei, R. Brunelli, G. Greco, L. Lenzi, G. Maulucci, E. Nicolai, M. Papi, G. Arcovito, et al. 2008. Low density lipoprotein misfolding and amyloidogenesis. FASEB J. 22: 2350-2356. (Pubitemid 351948653)
11. Lund-Katz, S., J. A. Ibdah, J. Y. Letizia, M. T. Thomas, and M. C. Phillips. 1988. A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor. J. Biol. Chem. 263: 13831-13838.
12. Aviram, M., S. Lund-Katz, M. C. Phillips, and A. Chait. 1988. The infl uence of the triglyceride content of low density lipoprotein on the interaction of apolipoprotein B-100 with cells. J. Biol. Chem. 263: 16842-16848. (Pubitemid 18268867)
13. Lund-Katz, S., P. M. Laplaud, M. C. Phillips, and M. J. Chapman. 1998. Apolipoprotein B-100 conformation and particle surface charge in human LDL subspecies: implication for LDL receptor interaction. Biochemistry. 37: 12867-12874. (Pubitemid 28433519)
14. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
15. Sánchez-Quesada, J. L., M. Camacho, R. Antón, S. Benítez, L. Vila, and J. Ordóñez-Llanos. 2003. Electronegative LDL of FH subjects: chemical characterization and induction of chemokine release from human endothelial cells. Atherosclerosis. 166: 261-270. (Pubitemid 36071684)
16. Wishart, D. S., C. G. Bigam, J. Yao, F. Abildgaard, H. J. Dyson, E. Oldfield, J. L. Markley, and B. D. Sykes. 1995. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J. Biomol. NMR. 6: 135-140.
17. Weisgraber, K. H., T. L. Innerarity, and R. W. Mahley. 1978. Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. J. Biol. Chem. 253: 9053-9062.
18. Mahley, R. W., T. L. Innerarity, and K. H. Weisgraber. 1980. Alterations in metabolic activity of plasma lipoproteins following selective chemical modification of the apoproteins. Ann. N. Y. Acad. Sci. 348: 265-280.
19. Henriksen, T., E. M. Mahoney, and D. Steinberg. 1983. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis. 3: 149-159. (Pubitemid 13136501)
20. Klein, R. L., M. Laimins, and M. F. Lopes-Virella. 1995. Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects. Diabetes. 44: 1093-1098.
21. Nigon, F., P. Lesnik, M. Rouis, and M. J. Chapman. 1991. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J. Lipid Res. 32: 1741-1753.
22. Sánchez-Quesada, J. L., S. Benítez, C. Otal, M. Franco, F. Blanco-Vaca, and J. Ordóñez-Llanos. 2002. Density distribution of electronegative LDL in normolipemic and hyperlipemic subjects. J. Lipid Res. 43: 699-705. (Pubitemid 34477896)
23. Chen, H. H., B. D. Hosken, M. Huang, J. W. Gaubatz, C. L. Myers, R. D. Macfarlane, H. J. Pownall, and C. Y. Yang. 2007. Electronegative LDLs from familial hypercholesterolemic patients are physicochemically heterogeneous but uniformly proapoptotic. J. Lipid Res. 48: 177-184.
24. Chen, C. H., T. Jiang, J. H. Yang, W. Jiang, J. Lu, G. K. Marathe, H. J. Pownall, C. M. Ballantyne, T. M. McIntyre, P. D. Henry, et al. 2003. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation. 107: 2102-2108.
25. Damasceno, N. R., A. Sevanian, E. Apolinário, J. M. Oliveira, I. Fernandes, and D. S. Abdalla. 2006. Detection of electronegative low density lipoprotein (LDL-) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassays. Clin. Biochem. 39: 28-38.
26. Demuth, K., I. Myara, B. Chappey, B. Vedie, M. A. Pech-Amsellem, M. E. Haberland, and N. Moatti. 1996. A cytotoxic electronegative LDL subfraction is present in human plasma. Arterioscler. Thromb. Vasc. Biol. 16: 773-783. (Pubitemid 26179366)